# Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)

> **NCT00837655** · NA · WITHDRAWN · sponsor: **Karolinska Institutet**

## Conditions studied

- Kidney Failure, Chronic
- End-Stage Renal Disease
- Insulin Resistance
- Hyperphosphatemia

## Interventions

- **DRUG:** Sevelamer
- **DRUG:** Calcium carbonate

## Key facts

- **NCT ID:** NCT00837655
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI retired
- **Last updated:** 2012-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837655, "Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00837655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*